The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

Approval of the tetracycline antibiotic for this indication was supported by data from two multicenter phase III trials -- ...

The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand name for its 40mg minocycline hydrochloride extended-release capsules, to be used in the treatment ...

Rosacea is thought to affect around 5% of the global population. Credit: Alona Siniehina / Shutterstock. The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...

Few children and teens develop rosacea, but it’s worth considering if your child frequently has any of the following: Left untreated, rosacea can worsen. In children, the long-lasting flushing can ...

And while you may now be better equipped to make them go away (facials, laser treatments and fancier skincare products), you ...

Approval of the tetracycline antibiotic for this indication was supported by data from two multicenter phase III trials -- MVOR-1 and MVOR-2-- involving 653 adults with papulopustular rosacea.